EN | UA
EN | UA

Help Support

Back

Effectiveness of H. pylori elimination using four-drug regimen in duodenal ulcer

duodenal ulcer duodenal ulcer
duodenal ulcer duodenal ulcer

A trial was conducted to evaluate the effectiveness of H. pylori elimination treatment using a four-drug combination of Tinidazole, Tetracycline, Bismuth, and Rabeprazole in people with duodenal ulcers.

See All

Key take away

In patients with duodenal ulcers, a combination of Tinidazole, Tetracycline, Bismuth, and Rabeprazole is highly efficient in H. pylori elimination.

Background

A trial was conducted to evaluate the effectiveness of H. pylori elimination treatment using a four-drug combination of Tinidazole, Tetracycline, Bismuth, and Rabeprazole in people with duodenal ulcers.

Method

Subjects diagnosed with duodenal ulcers underwent gastrointestinal endoscopy, gastric mucosa biopsy for a rapid urease test, and histopathology to identify H. pylori bacteria both before and following therapy. A 14-day regimen of Tinidazole, Tetracycline, Bismuth, and Rabeprazole was given for  eliminating H. pylori.

Result

As per the intention to treat and per protocol analysis, the success rate for H. pylori elimination was 82.4% and 91.3%, respectively. Compared to females' success rate of 70.6%, males had an elimination rate of 96.0%.

Conclusion

Men had better H. pylori elimination outcomes than women when treated with a combination of Tinidazole, Tetracycline, Bismuth, and Rabeprazole.

Source:

Gastroenterology Insights

Article:

Efficacy of Helicobacter pylori Eradication Based on Rabeprazole–Bismuth–Tetracycline–Tinidazole Regimen in Vietnamese Patients with Duodenal Ulcers

Authors:

Liem Thanh Nguyen et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: